101 related articles for article (PubMed ID: 6592167)
21. A lipophilic iron chelator induces an enhanced proliferation of human erythroleukaemia (HEL) cells.
Ekblom P; Landschulz W; Andersson LC
Scand J Haematol; 1986 Mar; 36(3):258-62. PubMed ID: 3458297
[TBL] [Abstract][Full Text] [Related]
22. Cell cycle effects of iron depletion on T-47D human breast cancer cells.
Reddel RR; Hedley DW; Sutherland RL
Exp Cell Res; 1985 Dec; 161(2):277-84. PubMed ID: 2998833
[TBL] [Abstract][Full Text] [Related]
23. The iron-chelating agent picolinic acid enhances transferrin receptors expression in human erythroleukaemic cell lines.
Testa U; Louache F; Titeux M; Thomopoulos P; Rochant H
Br J Haematol; 1985 Jul; 60(3):491-502. PubMed ID: 2990522
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms regulating the synthesis of transferrin receptors and ferritin in human erythroleukemic cell lines.
Louache F; Pelosi E; Titeux M; Peschle C; Testa U
FEBS Lett; 1985 Apr; 183(2):223-7. PubMed ID: 2985429
[TBL] [Abstract][Full Text] [Related]
25. Role of heme-hemopexin in human T-lymphocyte proliferation.
Smith A; Eskew JD; Borza CM; Pendrak M; Hunt RC
Exp Cell Res; 1997 May; 232(2):246-54. PubMed ID: 9168799
[TBL] [Abstract][Full Text] [Related]
26. Iron increases MMP-9 expression through activation of AP-1 via ERK/Akt pathway in human head and neck squamous carcinoma cells.
Kaomongkolgit R; Cheepsunthorn P; Pavasant P; Sanchavanakit N
Oral Oncol; 2008 Jun; 44(6):587-94. PubMed ID: 17936676
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro.
Trowbridge IS; Lopez F
Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1175-9. PubMed ID: 6280171
[TBL] [Abstract][Full Text] [Related]
28. Regulation of proteolytic activity of Vibrio vulnificus by iron-containing compounds.
Simpson LM; Oliver JD
Microb Pathog; 1993 Mar; 14(3):249-52. PubMed ID: 8321126
[TBL] [Abstract][Full Text] [Related]
29. Apotransferrin stimulation of thyroid hormone dependent rat pituitary tumor cell growth in serum-free chemically defined medium: role of FE(III) chelation.
Eby JE; Sato H; Sirbasku DA
J Cell Physiol; 1993 Sep; 156(3):588-600. PubMed ID: 8360262
[TBL] [Abstract][Full Text] [Related]
30. Involvement of PKC and ROS in the cytotoxic mechanism of anti-leukemic decursin and its derivatives and their structure-activity relationship in human K562 erythroleukemia and U937 myeloleukemia cells.
Kim HH; Sik Bang S; Seok Choi J; Han H; Kim IH
Cancer Lett; 2005 Jun; 223(2):191-201. PubMed ID: 15896453
[TBL] [Abstract][Full Text] [Related]
31. Transferrin synthesis by small cell lung cancer cells acts as an autocrine regulator of cellular proliferation.
Vostrejs M; Moran PL; Seligman PA
J Clin Invest; 1988 Jul; 82(1):331-9. PubMed ID: 2839550
[TBL] [Abstract][Full Text] [Related]
32. Tritrichomonas foetus: iron acquisition from lactoferrin and transferrin.
Tachezy J; Kulda J; Bahníková I; Suchan P; Rázga J; Schrével J
Exp Parasitol; 1996 Jul; 83(2):216-28. PubMed ID: 8682190
[TBL] [Abstract][Full Text] [Related]
33. Transferrin receptor 2 is frequently expressed in human cancer cell lines.
Calzolari A; Oliviero I; Deaglio S; Mariani G; Biffoni M; Sposi NM; Malavasi F; Peschle C; Testa U
Blood Cells Mol Dis; 2007; 39(1):82-91. PubMed ID: 17428703
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of growth of the lymphocyte lines by deferoxamine under various iron-supply conditions.
Kovár J; Seligman P; Gelfand EW
Folia Biol (Praha); 1993; 39(1):29-39. PubMed ID: 8348983
[TBL] [Abstract][Full Text] [Related]
35. Involvement of transferrin in the reduction of iron by the transplasma membrane electron transport system.
Löw H; Grebing C; Lindgren A; Tally M; Sun IL; Crane FL
J Bioenerg Biomembr; 1987 Oct; 19(5):535-49. PubMed ID: 3693344
[TBL] [Abstract][Full Text] [Related]
36. Essential fatty acids and iron are involved at distinct stages of the proliferative cycle but not in the activation of human T cells.
Or R; Kovar J; Domenico J; Gelfand EW
Clin Immunol Immunopathol; 1992 Mar; 62(3):314-20. PubMed ID: 1371729
[TBL] [Abstract][Full Text] [Related]
37. Regulation of HeLa cell transferrin receptors.
Ward JH; Kushner JP; Kaplan J
J Biol Chem; 1982 Sep; 257(17):10317-23. PubMed ID: 6286649
[TBL] [Abstract][Full Text] [Related]
38. Expression of transferrin receptors in phytohemagglutinin-stimulated human T-lymphocytes. Evidence for a three-step model.
Pelosi E; Testa U; Louache F; Thomopoulos P; Salvo G; Samoggia P; Peschle C
J Biol Chem; 1986 Mar; 261(7):3036-42. PubMed ID: 3005277
[TBL] [Abstract][Full Text] [Related]
39. Replacement of transferrin by simple iron compounds for MDCK cells grown and subcultured in serum-free medium.
Keenan J; Clynes M
In Vitro Cell Dev Biol Anim; 1996 Sep; 32(8):451-3. PubMed ID: 8889596
[No Abstract] [Full Text] [Related]
40. Differentiation of human erythroleukemia K562 cells without chemical inducer and the role of iron-saturated transferrin.
Murate T; Kaneda T; Hotta T; Goto S
Nihon Ketsueki Gakkai Zasshi; 1988 Sep; 51(6):1006-15. PubMed ID: 3201894
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
